Setting a Research Agenda for Ductal Carcinoma in Situ That Meets the Current Need for Change

Annals of Internal Medicine

Volumn 160, Issue 7, 2014, Pages 511-512

  Esserman, Laura ^a   Alvarado, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BREAST CARCINOMA; BREAST CELL; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESEARCH; CARCINOMA IN SITU; CELL STRUCTURE; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; DECISION MAKING; DECISION SUPPORT SYSTEM; EDITORIAL; FAMILY HISTORY; HUMAN; HYPERPLASIA; INTERVENTION STUDY; INTRADUCTAL CARCINOMA; LIFESTYLE MODIFICATION; MASTECTOMY; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PARTIAL MASTECTOMY; PATHOLOGIST; PRECANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RESEARCH PRIORITY; RISK FACTOR; RISK REDUCTION; TUMOR INVASION; VALIDATION STUDY; WIDE EXCISION;

ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EVIDENCE-BASED MEDICINE; FEMALE; FORECASTING; HUMANS; PATIENT OUTCOME ASSESSMENT; RESEARCH;

EID: 84897468444     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0435     Document Type: Editorial

References (10)

1. Gierisch JM, Myers ER, Schmit KM, Crowley MJ, McCrory DC, Chatterjee R, et al. Prioritization of research addressing management strategies for ductal carcinoma in situ. Ann Intern Med. 2014;160:484-91.
2. Wells CJ, O'Donoghue C, Ojeda-Fournier H, Retallack HE, Esserman LJ. Evolving paradigm for imaging, diagnosis, and management of DCIS. J Am Coll Radiol. 2013;10:918-23. [PMID: 24295941]
3. Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366. [PMID: 24519768]
4. Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retel VP, Mook S, et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat. 2011;130:725-34. [PMID: 21892702]
5. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310:797-8. [PMID: 23896967]
6. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14:1008-11. [PMID: 15824180]
7. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011;129:165-73. [PMID: 21390494]
8. Moyer VA; U.S. Preventive Services Task Force. Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;159: 698-708. [PMID: 24061412]
9. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-6. [PMID: 8292119]
10. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987-98. [PMID: 23484825]